Skip to main content
Apollo Hospitals Enterprises Ltd. logo

Apollo Hospitals Enterprises Ltd. — Investor Relations & Filings

Ticker · APOLLOHOSP ISIN · INE437A01024 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,913 across all filing types
Latest filing 2024-08-13 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS APOLLOHOSP

About Apollo Hospitals Enterprises Ltd.

https://www.apollohospitals.com/

Apollo Hospitals Enterprises Ltd. is an integrated healthcare provider operating a vast network of multi-specialty hospitals, primary care facilities, and diagnostic centers. The organization offers specialized clinical services in fields such as cardiology, oncology, neurology, orthopedics, and multi-organ transplants. Its business model encompasses an extensive retail pharmacy chain and a digital health ecosystem, Apollo 24/7, providing teleconsultations and home-based care. The company leverages advanced medical infrastructure, including robotic surgery systems and proton therapy, to provide complex tertiary care. Serving both domestic and international patients, the company integrates preventive health screenings, emergency medical services, and clinical research. The focus remains on delivering comprehensive medical solutions through a vertically integrated model that spans from primary clinics to advanced quaternary care centers.

Recent filings

Filing Released Lang Actions
as per annexure enclosed
Interim / Quarterly Report Classification · 95% confidence The document is a review report by Deloitte Haskins & Sells LLP on the standalone and consolidated unaudited financial results of Apollo Hospitals Enterprise Limited for the three months ended June 30, 2024. It references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results. The document explicitly states it is a review of interim financial information, which is less comprehensive than an audit and does not express an audit opinion. The presence of detailed financial results for a quarter and the nature of the document as a review report on these results aligns with an Interim / Quarterly Report (IR). The document length (11,330 characters) and content indicate it is the report itself, not merely an announcement or certification. Therefore, the correct classification is IR (Interim / Quarterly Report). Q1 2025
2024-08-13 English
Limited Review Report
Interim / Quarterly Report Classification · 95% confidence The document is a review report by Deloitte Haskins & Sells LLP on the standalone and consolidated unaudited financial results of Apollo Hospitals Enterprise Limited for the three months ended June 30, 2024. It references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results. The document explicitly states it is a review of interim financial information, which is less comprehensive than an audit and does not express an audit opinion. The presence of detailed financial results for a quarter and the nature of the document as a review report on these results aligns with an Interim / Quarterly Report (IR). The document length (11,330 characters) and content indicate it is the report itself, not merely an announcement or certification. Therefore, the correct classification is IR (Interim / Quarterly Report). Q1 2025
2024-08-13 English
As per annexure enclosed
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Apollo Hospitals Enterprise Limited Earnings Update Q1 FY25' and contains detailed financial performance data, segment-wise updates, and operational metrics for the first quarter of fiscal year 2025. It includes revenue, EBITDA, margin, and PAT growth figures, as well as business segment descriptions and operational statistics. The content is comprehensive and focused on quarterly financial results and business performance, typical of an Interim / Quarterly Report. There is no indication that this is a brief announcement or a transcript, nor is it a full annual report or an earnings release with only highlights. The length (15,000 characters) and detailed financial data confirm it is a substantive quarterly report rather than a mere announcement or presentation. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2024-08-13 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Apollo Hospitals Enterprise Limited Earnings Update Q1 FY25' and contains detailed financial performance data, segment-wise updates, and operational metrics for the first quarter of fiscal year 2025. It includes revenue, EBITDA, margin, and PAT growth figures, as well as business segment descriptions and operational statistics. The content is comprehensive and focused on quarterly financial results and business performance, typical of an Interim / Quarterly Report. There is no indication that this is a brief announcement or a transcript, nor is it a full annual report or an earnings release with only highlights. The length (15,000 characters) and detailed financial data confirm it is a substantive quarterly report rather than a mere announcement or presentation. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2025
2024-08-13 English
As per annexure enclosed
Regulatory Filings
2024-08-13 English
Outcome of Board Meeting
Regulatory Filings
2024-08-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.